Davis Capital Management Spdr Ser Tr Spdr S&P Biotech E Transaction History
Davis Capital Management
- $123 Billion
- Q4 2024
A detailed history of Davis Capital Management transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Davis Capital Management holds 352 shares of XBI stock, worth $32,545. This represents 0.03% of its overall portfolio holdings.
Number of Shares
352
Previous 352
-0.0%
Holding current value
$32,545
Previous $34.8 Million
8.85%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
915Shares Held
100MCall Options Held
28.4MPut Options Held
33.4M-
Goldman Sachs Group Inc New York, NY12.7MShares$1.18 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY12.3MShares$1.14 Billion0.1% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$853 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$742 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$717 Million0.45% of portfolio